According to a recent report issued by New Frontier Data, the U.S. CBD industry grew by nearly 40% in 2017, reaching $367 million in sales across hemp-derived and marijuana-derived markets. This marks the first year that sales of hemp-derived CBD products outpaced marijuana-derived CBD products.
Surging demand is expected to lift both markets higher and 2018 will be a break-out year for CBD, with the total market expanding to more than $500 million in sales. The CBD industry will grow to $1.2 billion by 2020, and nearly $2 billion by 2022.
Much of the recent growth has come from the demand for hemp-derived CBD for use in health and wellness products
Green Cures & Botanical Distribution Inc., (OTC:GRCU) is revenue-generating company that wholesales and retails hemp-infused nutritional, botanical, sports, and body care products. The company is currently Web-based and focuses on online retailing. Green Cures & Botanical Distribution Inc., operates a diverse portfolio of products and services within the botanical and cannabis industry, as permitted by law. From concept to production to distribution, Green Cures & Botanical Distribution Inc., is continuously creating and introducing products that promote a healthy life style.
The company recently announced that it has successfully pre-launched two new CBD-infused protein supplement products, one product being vegan, while the other is whey-based.
Green Cures & Botanical Distribution Inc. is providing consumers with alternative dietary needs, access to clean, pure, and potent protein supplementation through CBD Iso Pro Vegan Chocolate Protein Powder and CBD Iso Pro Whey Chocolate Protein Powder. These supplements will help athletes recover more quickly, improve endurance, and save calories vs. sugar-added protein supplement competitors. More details regarding our Full Launch of these innovative products will be forthcoming soon.
Last year, Green Cures and Botanical Distribution Inc. (OTC PINK: GRCU has entered discussions with leading CBD brands. Following up on previous discussion about potential entry into the CBD market, the company determined that the timing is great for entering the CBD space, as more states seek to legalize the substance over the coming years.
Working with CBD industry veterans and seasoned experts will give Green Cures the opportunity to quickly get up to speed and develop profitable new product lines, along with new distribution channels.
The company is making entry into the CBD space a high priority, and will be working diligently to move multiple deals through over the coming months.
This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and CG undertakes no obligation to update such statements.
You should not rely on the information presented; you should do independent research to form your own opinion and decision. Information contained in our disseminated emails does not constitute investment, legal or tax advice upon which you should rely. The purchase of high-risk securities may result in the loss of your entire investment. Advertisements received by you are not a solicitation or recommendation to buy securities of the advertised company. Full Disclaimer: http://www.cannagreed.com/disclaimer/